Notch Therapeutics Email Format
Biotechnology ResearchBritish Columbia, Canada2-10 Employees
Notch Therapeutics is a biotechnology company pursuing improvements in cell therapies through a T cell-production platform that uses induced pluripotent stem cells. The technology enables precise control of notch signaling, addressing key challenges in developing and manufacturing cell therapies. By doing so, it aims to produce a uniform and scalable supply of therapeutic T cells that could improve patient outcomes. Notch has described developing a pipeline of renewable stem cell-derived cancer immunotherapies. Based in Vancouver, British Columbia, Notch operates as a small biotechnology research firm. In 2023, it closed its Vancouver lab and redirected its focus to offices in Toronto and Seattle.